DE69831737D1 - Neurotrypsin - Google Patents

Neurotrypsin

Info

Publication number
DE69831737D1
DE69831737D1 DE69831737T DE69831737T DE69831737D1 DE 69831737 D1 DE69831737 D1 DE 69831737D1 DE 69831737 T DE69831737 T DE 69831737T DE 69831737 T DE69831737 T DE 69831737T DE 69831737 D1 DE69831737 D1 DE 69831737D1
Authority
DE
Germany
Prior art keywords
neurotrypsin
compositions
neurotrypsins
pharmaceutical
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831737T
Other languages
English (en)
Other versions
DE69831737T2 (de
Inventor
Peter Sonderegger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zurich Universität
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69831737D1 publication Critical patent/DE69831737D1/de
Publication of DE69831737T2 publication Critical patent/DE69831737T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69831737T 1997-04-26 1998-04-24 Neurotrypsin Expired - Lifetime DE69831737T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH96697 1997-04-26
CH00966/97A CH692507A5 (de) 1997-04-26 1997-04-26 Neurotrypsin als aktive Verbindung in einem Medikament.
PCT/IB1998/000625 WO1998049322A1 (en) 1997-04-26 1998-04-24 Neurotrypsin

Publications (2)

Publication Number Publication Date
DE69831737D1 true DE69831737D1 (de) 2006-02-09
DE69831737T2 DE69831737T2 (de) 2006-06-29

Family

ID=4199334

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831737T Expired - Lifetime DE69831737T2 (de) 1997-04-26 1998-04-24 Neurotrypsin

Country Status (9)

Country Link
US (1) US7666613B2 (de)
EP (1) EP0977871B1 (de)
AT (1) ATE305517T1 (de)
AU (1) AU6849198A (de)
CH (1) CH692507A5 (de)
DE (1) DE69831737T2 (de)
DK (1) DK0977871T3 (de)
ES (1) ES2251077T3 (de)
WO (1) WO1998049322A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1132778A (ja) * 1997-07-24 1999-02-09 Suntory Ltd 新規セリンプロテアーゼ
JP4439120B2 (ja) 1998-10-16 2010-03-24 大塚製薬株式会社 新生血管特異的ペプチド
EP1868989A2 (de) * 2005-03-30 2007-12-26 University of Zurich Inhibitoren von neurotrypsin und deren bestimmung
EP2081081A4 (de) * 2006-10-11 2009-11-04 Sharp Kk Flüssigkristallanzeige
WO2012059443A2 (en) 2010-11-01 2012-05-10 Neurotune Ag Novel neurotrypsin inhibitors
WO2012059442A2 (en) 2010-11-01 2012-05-10 Neurotune Ag Neurotrypsin inhibitors
EP2631657A1 (de) * 2012-02-25 2013-08-28 Neurotune AG Immunoassay zur Detektion des 22kDa-C-terminalen-Fragments (CAF) von Agrin
CN112770776B (zh) * 2018-07-30 2025-08-19 瑞德库尔有限责任公司 用于样品处理或分析的方法和系统
WO2020076976A1 (en) 2018-10-10 2020-04-16 Readcoor, Inc. Three-dimensional spatial molecular indexing
WO2021155063A1 (en) 2020-01-29 2021-08-05 Readcoor, Llc Compositions and methods for analyte detection
US20220049303A1 (en) 2020-08-17 2022-02-17 Readcoor, Llc Methods and systems for spatial mapping of genetic variants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1132778A (ja) * 1997-07-24 1999-02-09 Suntory Ltd 新規セリンプロテアーゼ
AU2003298786A1 (en) * 2002-11-26 2004-06-18 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
WO2004065576A2 (en) * 2003-01-15 2004-08-05 Millennium Pharmaceuticals, Inc. Methods and compositions for the treatment of urological disorder using differential expressed polypeptides

Also Published As

Publication number Publication date
CH692507A5 (de) 2002-07-15
EP0977871B1 (de) 2005-09-28
ES2251077T3 (es) 2006-04-16
US7666613B2 (en) 2010-02-23
DK0977871T3 (da) 2006-01-16
DE69831737T2 (de) 2006-06-29
US20050032694A1 (en) 2005-02-10
EP0977871A1 (de) 2000-02-09
AU6849198A (en) 1998-11-24
WO1998049322A1 (en) 1998-11-05
ATE305517T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
TR199501325A2 (tr) Protez dis sabitlestirme terkipleri.
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
TR199800375A3 (tr) Selant kompozisyonlari.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
DE69732309D1 (de) Primerzusammensetzungen für den Dentalbereich
EA199900373A2 (ru) Фармацевтические композиции
YU15299A (sh) Farmaceutski sastavi
DE69905170T2 (de) Thiazolopyrimidinderivate
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
TR199501650A2 (tr) Agiz bilesimleri.
TR199501645A2 (tr) Agiz bilesimleri.
DK0977871T3 (da) Neurotrypsin
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
BG100248A (bg) Инхибитори на скваленсинтетаза
HN1998000045A (es) Composiciones farmaceuticas
ES2186807T3 (es) Inhibidores de trombina.
DZ2548A1 (fr) Compositions de sertraline solubilisée.
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
TR199501649A2 (tr) Agiz bilesimleri.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
ATE223427T1 (de) Modifizierte kojibioside analoge

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DR. WEIHRAUCH & HAUSSINGEN PATENT- UND RECHTSANWAE

8327 Change in the person/name/address of the patent owner

Owner name: UNIVERSITAET ZUERICH, ZUERICH, CH